Email this article 
endomÉvaluation du risque de cancer du sein héréditaire : BRCA1 et BRCA2
Abstract
La récente prolifération des travaux de recherche génétique sur le cancer du sein héréditaire a rehaussé notre compréhension des influences génétiques sur la santé et sur les maladies. Ces progrès scientifiques ont des répercussions importantes pour les infirmières cliniciennes en oncologie et les infirmières en pratique avancée. Les auteures de cet article utilisent le Human Response to Illness Model [modèle de réponse humaine à la maladie] (Mitchell, Gallucci & Fought, 1991) afin d’acquérir une compréhension approfondie du cancer du sein concernant la réponse humaine aux mutations génétiques. Il soulignera donc la documentation portant sur les perspectives physiologiques, pathophysiologiques, comportementales et expérientielles liées au cancer du sein dû à une mutation de BRCA. Ces résultats fondés sur la recherche procureront aux infirmières en oncologie les compétences leur permettant d’élaborer un plan de soins holistiques pour les femmes ayant un risque génétique—actuel ou éventuel—de cancer du sein.
Full Text:
PDFReferences
Barse, P.M. (2006). How to Perform a Genetic Assessment. In A.S.
Tranin, A. Masny & J. Jenkins (Eds.), Genetics in Oncology Practice:
Cancer Risk Assessment (2nd ed., pp. 57–73). Pittsburgh, PA:
Oncology Nursing Association.
Berliner, J.L., & Fay, A.M. (2007). Risk assessment and genetic
counseling for hereditary breast and ovarian cancer:
Recommendations of the National Society of Genetic Counselors.
The American Journal of Human Genetics, 16, 241–260.
Brown, K.L., Moglia, D.M., & Grumet, S. (2007). Genetic counseling for
breast cancer risk: General concepts, challenging themes and
future directions. Breast Disease, 27, 69–96.
Carroll, J.C., Cremin, C., Allanson, J., Blaine, S.M., Dorman, H.,
Gibbons, C.A., et al. (2008). Hereditary breast and ovarian
cancers. Official Publication of the College of Family Physicians of
Canada, 54(12), 1691–1692.
Carter, R.F. (2001). BRCA1, BRCA2 and breast cancer: A concise
clinical review. Clinical and Investigative Medicine, 24(3), 147–157.
Chapman, D.D. (2007). Cancer genetics. Seminars in Oncology
Nursing, 23(1), 2–9.
Cuningham, K. (2008). Smoking and risk of breast cancer in carriers
of mutations in BRCA1 or BRCA2 aged less than 50 years. Breast
Cancer Research and Treatment, 109, 67–75.
Ensenauer, R.E., Michels, V.V., & Reinke, S.S. (2005). Genetic testing:
practical, ethical, and counseling considerations. Mayo Clinical
Proceedings, 80(1), 63–73.
Evans, J.P., Skrzynia, C., Susswein, L., & Harlan, M. (2005). Genetics
and the young woman with breast cancer. Breast Diseases, 23,
–29.
Fackenthal, J.D., & Olopade, O.I. (2007). Breast cancer risk associated
with BRCA1 and BRCA2 in diverse populations. Nat Rev Cancer,
(12), 937–48.
Horsman, D., Wilson, B.J., Avard, D., Meschino, W.S., Sing, C.K.,
Plante, M., et al. On behalf of the National Hereditary Cancer Task
Force. (2007). Clinical management recommendations for
surveillance and risk-reduction strategies for hereditary breast
and ovarian cancer among individuals carrying a deleterious
BRCA1 or BRCA2 mutation. Journal of Obstetrics and
Gynaecology Canada, 29(1), 45–60.
Kotsopoulos, J., Lubinski, J., Lynch, H. T., Klijn, J., Ghadirian, P., &
Neuhausen, S.L., et al. The Hereditary Breast Cancer Clinical
Study Group. (2007). Age at first birth and the risk of breast
cancer in BRCA1 and BRCA2 mutation carriers. Breast Cancer
Research and Treatment, 105(2), 221–228.
Loescher, L.J., & Whitesell, L. (2006). The Biology of Cancer. In A.S.
Tranin, A. Masny & J. Jenkins (Eds.), Genetics in oncology practice:
Cancer risk assessment (2nd ed., pp. 23–55). Pittsburgh, PA:
Oncology Nursing Association.
McGuire, V., John, E.M., Felberg, A., Haile, R.W., Boyd, N.F., & Thomas,
D.C., et al. (2006). No increased risk of breast cancer associated
with alcohol consumption among carriers of BRCA1 and BRCA2
mutations ages <50 years. Cancer Epidemiology, Biomakers &
Prevention, 15, 1565–1567.
Mitchell, P.H., Gallucci, B., & Fought, S.G. (1991). Perspectives on human
response to health and illness. Nursing Outlook, 39(4), 154–157.
Narod, S.A., & Foulkes, W.D. (2004). BRCA1 and BRCA2: 1994 and
beyond. Nature Reviews Cancer, September(4), 665–676.
Nkondjock, A., & Ghadirian, P. (2004). Epidemiology of breast cancer
among BRCA mutation carriers: An overview. Cancer Letters, 205,
–8.
Petrucelli, N., Daly, M.B., Culver, J.O., Feldman, G.L. (2007). BRCA1
and BRCA2 hereditary breast/ovarian cancer. Gene Reviews.
Retrieved from http://www.ncbi.nlm.nih.gov/bookshelf/br.fcgi?
book=gene∂=brca1
Phelps, C., Wood, F., Bennett, P., Brain, K., & Gray, J. (2007).
Knowledge and expectations of women undergoing cancer genetic
risk assessment: A qualitative analysis of free-test questionnaire
comments. Journal of Genetic Counseling, 16(4), 505–514.
Ronckers, C.M., Erdmann, C.A., & Land, C.E. (2005). Radiation and
breast cancer: A review of current evidence. Breast Cancer
Research, 7(1), 21–32.
Rosen, E.M., Fan, S., & Isaacs, C. (2005). Review BRCA1 in hormonal
carcinogenesis; basic and clinical research. Endocrine-Related
Cancer, 12(3), 533–548.
Schlich-Bakker, K.J., ten Kroode, H.F.J., & Ausems, M.G.E.M. (2006). A
literature review of the psychological impact of genetic testing
on breast cancer patients. Patient Education and Counseling,
(1), 13–20.
Schwartz, M.D., Peshkin, B.N., Hughes, C., Main, D., Isaacs, C., &
Lerman. C. (2002). Impact of BRCA1/BRCA2 mutation testing on
psychologic distress in a clinic-based sample. Journal of Clinical
Oncology, 20(2), 514–520.
Sifri, R., Gangadharappa, S., & Acheson, L.S. (2004). Identifying and
testing for hereditary susceptibility to common cancers. A
Cancer Journal for Clinicians, 54, 309–326.
Sivell, S., Iredale, R., Gray, J., & Coles, B. (2007). Cancer genetics risk
assessment for individuals at risk of familial breast cancer (Review).
Cochrane Database of Systematic Reviews, (2), CD003721, 1–30.
Smith, A.W., Dougall, A.L., Posluszny, D.M., Somers, T.J., Rubinstein,
W.S., & Baum, A. (2008). Psychological distress and quality of life
associated with genetic testing for breast cancer risk. Journal of
Psychosocial Oncology, 17, 767–773.
Société canadienne du cancer/Institut national du cancer du Canada
(2009). Statistiques canadiennes sur le cancer. ISSN 0835-2976.
Willey, S.C., & Cocilovo, C. (2007). Screening and follow-up of the
patient at high risk for breast cancer. Obstetrics and Gynecology,
(6), 1404–1416.
Yoshida, K., & Miki, Y. (2004). Role of BRCA1 and BRCA2 as
regulators of DNA repair, transcription and cell cycle in response
to DNA damage. Cancer Science, 95(11), 866–871.
Refbacks
- There are currently no refbacks.
